Question · Q4 2025
Robert Mason asked about the expected 25%+ growth for Paragon in 2026, an acceleration from its low-teens growth at acquisition, inquiring about the reasons for this acceleration and its implications for the broader Mirion nuclear power business. He also asked how the active NRC life extension activity for the existing reactor fleet manifests for Mirion in terms of orders, whether it's already in backlog or part of the future pipeline.
Answer
Brian Schopfer, CFO and Medical Group President, attributed Paragon's accelerated growth to strong order growth in 2025 and expansion into the DOE landscape. Thomas Logan, CEO and Chairman, described the strategic implications as profound, expecting increased wallet share from the installed base, stronger engagement with SMRs, and innovation cascading into the operating fleet and utility-scale reactors. Logan stated that life extensions, uprates, and modernization are critical for the global fleet, contributing to the 11% nuclear power growth in 2025, with content from previously decommissioned plants continuing to evolve.
Ask follow-up questions
Fintool can predict
MIR's earnings beat/miss a week before the call


